Pivotal Therapeutics (PVTTF) News Today $0.0018 0.00 (0.00%) As of 05/12/2023 Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Africa a crucial partner to achieving Global Pivotal State — South KoreaMay 19, 2024 | msn.comWikiLeaks Founder Julian Assange Facing Pivotal Moment in Long Fight to Stay Out of US CourtMay 19, 2024 | msn.comZuma in Court Seeking Right to Run in South Africa's Pivotal ElectionMay 10, 2024 | usnews.comKawhi Leonard Ruled Out for Clippers' Pivotal Game 5 Vs MavericksApril 30, 2024 | msn.comBiden Sees a $35 Price Cap for Insulin as a Pivotal Campaign Issue. It’s Not That Clear-CutApril 21, 2024 | usnews.comThe Latest | Jury Selection Enters a Pivotal Stretch as Trump's Hush Money Trial ResumesApril 18, 2024 | msn.comJury Selection in Trump Hush Money Trial Faces Pivotal Stretch as Former President Returns to CourtApril 18, 2024 | usnews.comAnti-Trump Republican Larry Hogan Navigates Dangerous Political Terrain in Pivotal Senate ContestApril 17, 2024 | usnews.comAmen Corner Proves Pivotal as Scottie Scheffler's Closest Pursuers Falter in Final Round of MastersApril 14, 2024 | msn.comSpotify target raised to new Street high at Pivotal ResearchApril 5, 2024 | investing.comProtembis GmbH: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal TrialApril 2, 2024 | finanznachrichten.deProtembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal TrialApril 2, 2024 | finance.yahoo.comJenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The LancetMarch 28, 2024 | finance.yahoo.comBuy Rating for Viridian Therapeutics Backed by Strong Financials and Promising Drug CandidateFebruary 28, 2024 | markets.businessinsider.comPivotal, the flying-car company backed by Google cofounder Larry Page, lays off 10% of staffFebruary 24, 2024 | businessinsider.comPivotal Delivers Four BlackFly light eVTOLs for U.S. Air Force evaluation; Contracted for Eight AircraftFebruary 22, 2024 | markets.businessinsider.comPivotal Commware Promotes FWA Without Limits at 2024 Mobile World Congress BarcelonaFebruary 22, 2024 | tmcnet.comDCC Animal Hospital onboards Dr. Prabhakaran Palanichamy as Senior Veterinary ExpertFebruary 9, 2024 | msn.comVertex's (VRTX) Q4 Earnings and Sales Surpass EstimatesFebruary 6, 2024 | msn.comGlobal Downstream Processing Market to Surpass 83.47 Billion by 2030 Driven by Rising Demand for BiopharmaceuticalsFebruary 5, 2024 | finance.yahoo.comVertex non-opioid painkiller shows positive results in critical late-stage trial on acute painJanuary 30, 2024 | msn.comViridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended ...December 18, 2023 | businesswire.comPivotal Life Sciences Announces the Closing of $389M for Pivotal bioVenture Partners Fund IIDecember 18, 2023 | finance.yahoo.comGlobal Semiconductor Industry Outlook 2024December 12, 2023 | finance.yahoo.comNuclear Medicine Market Valuation to Soar at 11.5% by 2030, Global Revenue to Exceed US$11 Bn: Fairfield Market ResearchDecember 12, 2023 | finance.yahoo.comPivotal Appoints Cyrus Sigari to its Board of DirectorsNovember 21, 2023 | markets.businessinsider.comGlobal Neuromuscular Disease Therapeutics Market to Surge by $6.51 Billion by 2027, Driven by Novel Approvals and Screening TestsOctober 25, 2023 | uk.finance.yahoo.comJenaValve Trilogy heart valve meets primary endpoints in pivotal trialOctober 25, 2023 | msn.comJenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy EndpointsOctober 24, 2023 | markets.businessinsider.comProtembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) StudyOctober 19, 2023 | venturebeat.comVideo Provides First Clear Views of WWII Aircraft Carriers Lost in the Pivotal Battle of MidwaySeptember 30, 2023 | usnews.comIn the Pivotal South Carolina Primary, Republican Candidates Search for a Path Against Donald TrumpSeptember 4, 2023 | usnews.comProtagonist Therapeutics: Evaluating Rusfertide's Potential For PVSeptember 4, 2023 | msn.comSVB Securities Maintains Viracta Therapeutics (VIRX) Outperform RecommendationAugust 15, 2023 | msn.comViracta Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 14, 2023 | markets.businessinsider.comHow Does Pivotal Response Training (PRT) for Children With Autism Work?August 9, 2023 | msn.comPivotal Research Sticks to Their Buy Rating for Liberty Broadband (LBRDK)August 7, 2023 | markets.businessinsider.comSERD Therapeutics Market Recording a Promising CAGR of 17.5% from 2023-2031 | Reveals InsightAce StuydJuly 25, 2023 | finance.yahoo.comAutolus Therapeutics Presents Positive Results from Pivotal Phase 2 FELIX study in adult r/r B-ALL at ASCOJune 2, 2023 | finance.yahoo.comTravere Therapeutics Announces Positive Topline Results from Cohort 6 in the Phase 1/2 COMPOSE Study of Pegtibatinase in Classical HomocystinuriaMay 31, 2023 | technews.tmcnet.comAutolus Therapeutics to hold Analyst call to highlight data at ASCO from the Pivotal Phase 2 FELIX study of obe-cel data in adult r/r B-ALLMay 22, 2023 | benzinga.comInsiders Rewarded With AU$135k Addition To Investment As Pivotal Metals Stock Hits AU$17mMay 9, 2023 | hk.finance.yahoo.comPivotal Research Remains a Buy on Dish Network (DISH)May 9, 2023 | markets.businessinsider.comPivotal Research Maintains Dish Network Corp - (DISH) Buy RecommendationMay 9, 2023 | msn.come-therapeutics hails "pivotal year" but sees its losses widenMay 5, 2023 | msn.comPivotal Research Maintains Hold Rating for Altice USA: Here's What You Need To KnowMay 5, 2023 | markets.businessinsider.comPivotal Therapeutics Inc. (PVTTF)April 23, 2023 | finance.yahoo.comCentury Park Portfolio Company, Pivotal Drive, Merges with Nova CPMApril 19, 2023 | benzinga.comPivotal Commware Lights Up mmWave Fixed Wireless Coverage in AtlantaApril 19, 2023 | tmcnet.comScottsdale-based Pivotal Group acquires Atlanta webcast companyApril 13, 2023 | bizjournals.com Get Pivotal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PVTTF and its competitors with MarketBeat's FREE daily newsletter. Email Address PVTTF Media Mentions By Week PVTTF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PVTTF News Sentiment▼0.000.78▲Average Medical News Sentiment PVTTF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PVTTF Articles This Week▼01▲PVTTF Articles Average Week Get Pivotal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PVTTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CLVR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PVTTF) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pivotal Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pivotal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.